A new warning sign of the Omicron variant of Covid-19 has potentially been identified.
Alongside having a cough, high temperature, a loss of your sense of smell and fatigue, the newest symptom you may experience after contracting the virus is a sense of confusion.
Now, an American health agency has identified a new symptom that is being described as an “emergency warning sign”, reports The Express.
The American Centers for Disease Control and Prevention (CDC) says people feeling this newfound sense of confusion should “seek medical care immediately”.
The ZOE COVID Symptom Study app, launched by health science company ZOE and King’s College London, has also reported new confusion as a possible symptom.
This confusion, often called delirium, can cause a change in your normal behaviour and has been reported by millions of app users.
According to the ZOE COVID Study, you can experience either hyperactive or hypoactive delirium.
However, the app does explain that this symptom mainly occurs in older people with Coronavirus.
While delirium might be a warning sign of Covid, it could also be signalling a variety of different health conditions so you should seek medical help, the NHS adds.
NHS Covid symptoms list:
- A high temperature – this means you feel hot to touch on your chest or back (you do not need to measure your temperature).
- A new, continuous cough – this means coughing a lot for more than an hour, or 3 or more coughing episodes in 24 hours (if you usually have a cough, it may be worse than usual).
- A loss or change to your sense of smell or taste – this means you’ve noticed you cannot smell or taste anything, or things smell or taste different to normal.
New Omicron symptom list:
- Scratchy throat
- Runny nose
- Lower back pain
- Night sweats
- Body aches
- Loss of appetite
The Department of Health and Social Care for England said: “Since the start of the pandemic we have acknowledged Covid-19 has a much longer list of symptoms than the ones used in the case definition, and experts keep the list of symptoms under review.”
Keep up with the latest news with our email alerts directly to your inbox. Sign up here.